SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-22-028234
Filing Date
2022-08-04
Accepted
2022-08-04 18:26:16
Documents
1
Period of Report
2022-08-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 6942
  Complete submission text file 0001140361-22-028234.txt   8526
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Issuer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1100 MASSACHUSETTS AVENUE CAMBRIDGE MA 02138
Business Address
Peluso Stephane (Reporting) CIK: 0001875939 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31141 | Film No.: 221138115